The science desk has several promising claims and the usual discipline problem: a useful article must not turn early evidence into certainty. Today’s digest says a cancer drug called daraxonrasib targets a growth-driving protein by physically enveloping it rather than blocking it conventionally, nearly doubling patient survival in trials. That is an intriguing mechanism, but the operating questions remain trial size, cancer type, comparator, endpoint definition, adverse events, and whether the effect survives broader testing.

The same caution applies to the Stanford appetite finding. The digest says researchers identified a naturally occurring molecule that suppresses appetite and reduces body weight comparably to GLP-1 drugs such as Ozempic, but without common side effects including nausea and muscle-mass loss. If confirmed, that would matter. For now, the phrase to hold onto is found, not deployed. Preclinical or early translational promise often narrows once dosing, duration, safety, and diverse patient populations enter the ledger.

The sunscreen item is more directly practical. The digest reports that the FDA cleared bemotrizinol, a long-lasting UVA filter already common in European sunscreens, for use in American products. If manufacturers adopt it, US consumers may get broader protection options after years of complaints that domestic sunscreen filters lagged European formulas. The follow-through will be product formulation, labeling, price, and availability.

Public health has a less glamorous notice. The digest says a Cyclospora outbreak has sickened more than 400 people across four US states, with investigators still searching for the contaminated food source. That is the part that matters most for behavior. Until the source is identified, broad alarm is less useful than watching health department guidance, preserving purchase records where relevant, and treating gastrointestinal symptoms seriously if exposure is suspected.

The climate desk adds a longer-range hazard. The digest cites a global modeling study projecting larger and more damaging hailstones as warming changes storm environments across mid-to-high latitude regions. That is not just weather trivia. Bigger hail affects crop loss, roofs, vehicles, solar farms, insurance models, and building codes.

Today’s science file therefore has two columns. On the left: therapies and molecules that may become important after evidence thickens. On the right: sunscreen approvals, outbreaks, and hail risk that already touch public health and planning.